Research & Development Market Research Reports & Industry Analysis
Bringing R&D costs and times down, therefore, means there are many opportunities to improve efficiencies, advance technological innovation, and economize and optimize. The pharmaceutical R&D category tracks both drug pipeline reports, competitive R&D strategies, and markets important and ancillary to the research efforts themselves, including activities in the biotech and sector that impinge upon the process.
Research & Development Industry Research & Market Reports
-
Genome-Based Drug Companies in China
... the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, ... Read More
-
Biotechnology Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
Biotechnology Industry Forecasts - China Focus
... and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the ... Read More
-
Global DNA and Gene Chip Market Analysis & Trends - Industry Forecast to 2030
... reach $24.8 billion by 2030. Based on our analysis the market is expected to grow at a CAGR of 15.6% from 2024 - 2030 timeframe. Some of the prominent trends that the market is witnessing ... Read More
-
Biophotonics
... of 10.8% over the analysis period 2023-2030. See-through Imaging Application, one of the segments analyzed in the report, is expected to record a 0.1% CAGR and reach US$34.1 Billion by the end of the analysis ... Read More
-
RNA Interference (RNAi)
... by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Drug Discovery & Development Application, one of the segments analyzed in the report, is expected to record a 16.4% CAGR and reach ... Read More
-
Biobank Management Systems Market By Sample Type (Absorbable Human Tissue & Organ Samples, Plant & Animal Samples, Microbial Samples) , By Application (Regenerative Medicine, Life Science Research, Clinical Research, Environmental Research) : Global Opportunity Analysis and Industry Forecast, 2024-2033
... and Industry Forecast, 2024-2033 The biobank management systems market was valued at $2.1 billion in 2023, and is projected to reach $4.6 billion by 2033, growing at a CAGR of 8.3% from 2024 to 2033. ... Read More
-
Biobanks
... of 8.0% over the analysis period 2023-2030. Physical / Real Biobanks, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$99.2 Billion by the end of the ... Read More
-
Human Embryonic Stem Cell (hESC) Research
... the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 6.4% over the analysis period 2023-2030. Regenerative Medicine Application, one of the segments analyzed in the report, is expected ... Read More
-
Drug Discovery Technologies
... by 2030, growing at a CAGR of 8.7% over the analysis period 2023-2030. Small Molecule Drugs Discovery Technologies, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach ... Read More
-
Biotech Business July 2024
... on biotechnology products and companies. It reports which universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies and their expected growth or decline. Read More
-
Synthetic Biology
... at a CAGR of 28.0% over the analysis period 2023-2030. Oligonucleotides & Synthetic DNA, one of the segments analyzed in the report, is expected to record a 29.3% CAGR and reach US$39.5 Billion by the ... Read More
-
Cancer Therapies
... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More
-
Viral Vector Manufacturing
... by 2030, growing at a CAGR of 18.3% over the analysis period 2023-2030. Retroviral Vectors, one of the segments analyzed in the report, is expected to record a 18.1% CAGR and reach US$954.6 Million by ... Read More
-
Virus Filtration Products
... by 2030, growing at a CAGR of 12.4% over the analysis period 2023-2030. Virus Filtration Kits & Reagents, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach ... Read More
-
Biotechnology Product Manufacturing
... (all based in the US), as well as Bayer and Merck Group (both based in Germany), CSL (Australia), Novo Nordisk (Denmark), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France). ... Read More
-
Pharma And Biotech CRM Software Global Market Report 2024
... And Medium Enterprise (SMEs)4) By Industry: Pharmaceuticals; BiotechCovering: Oracle Corporation; Salesforce.com Inc.; IQVIA Holdings Inc.; Trueblue Inc.; Cirrius Solutions Inc. Pharma And Biotech CRM Software Global Market Report 2024 from The Business Research Company provides ... Read More
-
Quantum Computing in Healthcare
... reach US$845.4 Million by 2030, growing at a CAGR of 37.4% over the analysis period 2023-2030. Quantum Computing in Healthcare Services, one of the segments analyzed in the report, is expected to record a 40.6% ... Read More
-
Stromal Vascular Fraction
... by 2030, growing at a CAGR of 4.5% over the analysis period 2023-2030. Isolation Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$99.5 Million by ... Read More
-
Growth Factors (Blood and Tissue)
... is expected to reach US$101.5 Billion by 2030, growing at a CAGR of 8.2% over the analysis period 2023-2030. Interferons, one of the segments analyzed in the report, is expected to record a 9.9% CAGR ... Read More
-
Global Lyophilized Reagent Beads Market Research Report 2024
... of 10.98% during the forecast period 2024-2030. North American market for Lyophilized Reagent Beads is estimated to increase from $ 111.73 million in 2023 to reach $ 224.94 million by 2030, at a CAGR of ... Read More
-
Hepatitis C Treatment
... by 2030, growing at a CAGR of 10.9% over the analysis period 2023-2030. HCV Protease Inhibitors Drug Class, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach ... Read More
-
The Science of Service: Elevating Customer Support in the Life Sciences 2024
... importance of customer service and technical support in purchase decisions and recommendations of life science suppliers, BioInformatics, part of Science and Medicine Group, designed a study that asked 414 global life scientists with recent customer ... Read More
-
Metabolomics: Technologies and Global Markets
... 32 data tables and 39 additional tables An overview of the global market for metabolomics, the study of small molecules, known as metabolites, in cells, biofluids, tissues and organisms Analysis of global market trends, featuring ... Read More
-
2024 Global: Life Science Analytics Market - Innovative Markets Forecast (2030) report
... the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 ... Read More
Research Assistance
